Madrigal Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
MDGL Madrigal Pharmaceuticals Inc
ADBE Adobe Inc
FATP Fat Projects Acquisition Corp
LGVC LAMF Global Ventures I Corp
SECO Secoo Holding Ltd
SGBXV Safe & Green Holdings Corp
CAH Cardinal Health Inc
CHEK Check Cap Ltd
NMG Nouveau Monde Graphite Inc
HYZN Hyzon Motors Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-B (THR-B), agonist being developed as a once-daily oral pill for the treatment of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). NASH is a liver disease that affects people with metabolic diseases, such as obesity and diabetes and non-alcoholic fatty liver disease (NAFLD).

Premarket

Last Trade
Delayed
$145.00
-5.94 (-3.94%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$150.94
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
13,701

10-day average volume:
541,684
13,701
  • Prev Close
    150.94
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    541.7K
  • Last (time)
    4:00p ET 09/25/23
  • Last (size)
    10
  • 52-Wk Range
    57.21 - 322.67
    LowHigh
  • (12/14/22 - 05/01/23)
    163.83%
  • 143.8%
  • Market Cap
    2.8B
  • Shares Outstanding
    18.5M
  • -18.64
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.7
  • 91.10
  • (% of float 08/31/23)
    12.00

Latest News

September 14, 2023
4:30 pm ET
Globe Newswire
6:56 am ET
Zacks
September 13, 2023
9:10 am ET
Globe Newswire
September 11, 2023
12:09 pm ET
MarketWatch
8:32 am ET
MarketWatch
7:00 am ET
Globe Newswire
August 08, 2023
8:00 am ET
Globe Newswire
July 17, 2023
8:00 am ET
Globe Newswire
July 10, 2023
8:32 am ET
Zacks
June 30, 2023
12:29 pm ET
MarketWatch
8:00 am ET
Globe Newswire
June 27, 2023
8:11 am ET
MarketWatch
April 19, 2023
10:36 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.